Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
There are no deductibles or co-payments
Product was packaged well
It marks the first time the federal agency has granted approval to an oral GLP-1 receptor agonist drug specifically for weight management
McDermott Will & Emery
Tirzepatide dose ranges (2.5-15 mg) are significantly higher than semaglutide dose ranges (0.25-2.4 mg), which means syringe capacity becomes a limiting factor much earlier with tirzepatide
Optimal outcomes require integration with dietary modification emphasizing whole foods and reduced processed carbohydrate intake, regular physical activity including both aerobic and resistance training, and management of other cardiovascular risk factors
US$ 25.35
US$ 23.79
US$ 27.63
US$ 20.50
US$ 25.29
US$ 28.53
US$ 20.09
US$ 24.27
US$ 20.37
US$ 21.81
US$ 21.62
US$ 23.26
US$ 29.80
